TABLE 1.
CLINICAL TRIALS EXAMINED WITH TREATMENT ARMS AND NUMBER OF UNIQUE WHITES AND AFRICAN AMERICANS IN EACH STUDY'S ARM
| Study Name (reference) | Arm | Number of Whites | Number of African Americans |
| BAGS (5) | Albuterol | 81 | 23 |
| Placebo | 81 | 26 | |
| SOCS (6) | Placebo | 35 | 9 |
| Sal | 39 | 4 | |
| ICS | 35 | 6 | |
| SLIC (7) | Placebo + ICS (pretaper) | 7 | 5 |
| Placebo only (posttaper) | 4 | 0 | |
| Sal + ICS (pretaper) | 23 | 11 | |
| Sal + ICS (sham taper) | 49 | 14 | |
| Sal only (posttaper) | 17 | 5 | |
| DICE (8) | Placebo | 5 | 1 |
| ICS | 76 | 16 | |
| MICE (9) | ICS | 22 | 4 |
| BARGE* (10) | Albuterol | 18 | 7 |
| Placebo | 22 | 6 | |
| IMPACT (11) | Budesonide | 57 | 9 |
| Placebo | 52 | 10 | |
| Zafirlukast | 45 | 11 | |
| SMOG* (12) | Montelukast | 5 | 6 |
| Beclomethasone | 5 | 1 | |
| SLIMSIT* (13) | Sal + montelukast | 42 | 29 |
| Sal + beclomethasone | 47 | 18 | |
| PRICE (14) | Placebo | 18 | 2 |
| ICS | 10 | 10 | |
| Total | 795 | 233 |
Definition of abbreviations: ICS = inhaled corticosteroids; Sal = salmeterol.
*
Denotes crossover trial in which individuals may have participated in more than one trial arm.